Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVOMILNACIPRAN HYDROCHLORIDE, with a corresponding US DMF Number 29733.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2016, and payment made on September 29, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II